Phospholipid Symposium 2011

Symposium on

Phospholipids in Pharmaceutical Research

12th – 13th of May 2011
Germany

Aspects

Phospholipids are already widely used in registered pharmaceutical formulations worldwide:

Lipid emulsions with phospholipids are used for parenteral nutrition.
The side effects of drugs can be considerably reduced by being packaged into liposomes, consisting of phospholipids.
Examples are the chemotherapeutics amphotericin B and doxorubicin.

However, their use could still be further extended as they might be able to replace almost all other emulsifiers and surfactants. Phospholipids are degraded by the body, can be well tolerated, are toxicologically harmless and can be used in suitable compositions in all systems.
But phospholipids can also act as active agents in pharmaceutics. In addition to the treatment of fatty livers, the positive effect of phospholipids has already been detected regarding the lipid metabolism, damages of the skin and the gastrointestinal tract.

The symposium “Phospholipids in Pharmaceutical Research” picks up the development of new applications and allows on fundamental research of phospholipids as well.

Aim of the symposium is to provide a platform for discussion and contact throughout the spectra of interests of phospholipid scientists.